## **Core Concept**
Leigh disease, also known as subacute necrotizing encephalomyelopathy, is a severe neurological disorder that usually becomes apparent in the first year of life. It is characterized by progressive loss of mental and motor skills (psychomotor regression) and typically results from mutations in mitochondrial DNA. The disorder is associated with abnormalities in energy production, particularly in the **electron transport chain** and **pyruvate metabolism**.

## **Why the Correct Answer is Right**
The correct answer, **pyruvate**, is related to the pathophysiology of Leigh disease. Pyruvate is a key metabolite in cellular energy production. In the mitochondria, pyruvate is converted into acetyl-CoA by **pyruvate dehydrogenase** (PDH), a critical step for the entry of glucose-derived carbon atoms into the citric acid cycle. A significant proportion of Leigh disease cases are caused by mutations in the **pyruvate dehydrogenase complex** (PDH complex) or in genes that encode components of the electron transport chain. The accumulation of pyruvate due to impaired PDH complex activity leads to a defect in the production of **ATP**, which is essential for cellular functions, particularly in high-energy-demanding tissues like the brain and muscles.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain disorders of amino acid metabolism can lead to accumulation of specific metabolites, Leigh disease is not primarily characterized by the accumulation of amino acids.
- **Option B:** Similarly, the primary issue in Leigh disease is not the accumulation of fatty acids but rather defects in energy production pathways.
- **Option C:** This option might relate to disorders of lactate metabolism, but Leigh disease's primary defect is not in lactate accumulation due to a problem at this step.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Leigh disease is that it often presents with **psychomotor regression**, **neurological deterioration**, and **elevated lactate levels** in blood and cerebrospinal fluid, reflecting the impaired mitochondrial energy production. Early diagnosis through genetic testing and biochemical assays (like measuring PDH activity) is crucial for managing the disease.

## **Correct Answer:** . pyruvate